Hiroto Egawa, M.D. Ph.D.

Hiroto Egawa, M.D. Ph.D.

Dr. Egawa graduated from Kyoto University and was trained as a hepatobiliary surgeon. He specialized in liver transplantation and contributed to establishing the LDLT program at Kyoto University. After his experience of 1300 LDLT, he moved to Tokyo Women’s Medical University and began a new program there. He has been the president of the Japan Society for Transplantation since 2017 and has a strong passion to develop transplant medicine in Japan. His scientific interest is transplant immunology, especially antibody-mediated rejection. He developed the “Japan Protocol” for ABO-incompatible liver transplantation and is still working energetically to improve the outcomes by further intervention using new drugs and new devices for immunological assessment.